The present invention provides compounds according to formula (I ) having the designations provided herein, and pharmaceutically acceptable salts and esters thereof These compounds inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.
Cis-imidazolines
申请人:——
公开号:US20040259884A1
公开(公告)日:2004-12-23
The present invention provides compounds according to formula I
1
having the designations provided herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.